Lupin enters into exclusive licensing agreement with Eli Lilly to commercialise and distribute CialisLupin has launched Cialis (tadalafil), an oral PDE5 inhibitor, for treatment of erectile dysfunction in adult males.
Cialis tablet is available in 10mg and 20 mg strengths. Lupin has acquired the rights to market, promote and distribute Lilly's erectile dysfunction product, Cialis through its specialty field force while Lilly will be responsible for manufacturing and importing the product.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)